Listen to our conversation with Trachtman about sparsentan's recent FDA approval for FSGS.
Howard Trachtman, MD
Advertisement
Howard Trachtman, MD, is an adjunct clinical professor of pediatrics at the University of Michigan.
Articles by Howard Trachtman, MD
A DUPLEX study investigator explains the data behind sparsentan's approval by the FDA.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5